idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Grafik: idw-Logo

idw - Informationsdienst
Wissenschaft

Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instance:
Share on: 
02/22/2018 09:35

Minimising risks of transplants

Dr. Susanne Langer Kommunikation und Presse
Friedrich-Alexander-Universität Erlangen-Nürnberg

    A bone marrow transplant is often the only therapy available to save leukaemia patients, but the risk of complications is high. In spite of devoting considerable time and effort to finding a suitable donor, nearly half of all patients experience an unwanted reaction of their immune system, which often attacks their skin and liver and in up to 50% of cases the intestines. Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) have succeeded in deciphering what causes this in some instances life-threatening inflammation of the intestines, possibly opening up new approaches for treatment.

    The severe immune reaction is triggered by a special form of the donor’s immune cells. These so-called T-lymphocytes recognise that the recipient’s cells are foreign and attack them. Researchers at FAU were able to show that this particular form of T-lymphocytes are controlled by a protein named BATF (‘basic leucin zipper ATF-like transcription factor’). ‘The BATF protein acts as a central switch in the donor’s T-lymphocytes,’ explains Prof. Dr. Kai Hildner from the Department of Medicine 1 – Gastroentrology, Pneumology and Endocrinology. ‘If the protein is turned on, it can lead to highly aggressive immune cells being developed, which massively increase inflammatory processes, interacting with other immune cells to cause extensive damage in the intestines after a stem cell transplant.’

    The group led by Professor Hildner in cooperation with the Department of Medicine 5 and working groups from Frankfurt, Regensburg and Würzburg were also able to demonstrate another connection: T-lymphocytes from the donor which migrate into the intestines release a messenger substance (GM-CSF – granulocyte-macrophage colony-stimulating factor) which triggers the inflammatory reaction in the intestines. When researchers used medication to prevent these specialised T-lymphocytes from developing and functioning, the inflammation in the intestines disappeared.

    The scientists hope that the discovery of this molecular mechanism will lead to new therapies being developed to influence inflammation in the intestines after transplants, further increasing patients’ chances of survival after a stem cell transplant.

    They have published the results of their research in the Journal of Clinical Investigation (DOI: 10.1172/JCI89242). Manuscript: https://www.jci.org/articles/view/89242

    Further information:
    Prof. Dr. Kai Hildner
    Phone: 09131 85 -35908
    kai.hildner@uk-erlangen.de


    Images

    Criteria of this press release:
    Journalists
    Medicine
    transregional, national
    Research results, Scientific Publications
    English


     

    Help

    Search / advanced search of the idw archives
    Combination of search terms

    You can combine search terms with and, or and/or not, e.g. Philo not logy.

    Brackets

    You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).

    Phrases

    Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.

    Selection criteria

    You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).

    If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).